Header image

Session D: Ways to improve HCV testing, treatment and care

Tracks
Track 2
Wednesday, September 11, 2019
2:00 PM - 3:20 PM
Montreal C & D, Level 11

Speaker

Agenda Item Image
Ms. Jennifer Broad
Community Support Worker
Toronto Community Hepatitis C Program; South Riverdale Community Health Center

TASK SHIFTING IN HCV TESTING AND RESEARCH: IMPROVING KNOWLEDGE OF HCV STATUS THROUGH A PEER OUTREACH HEPATITIS C POINT OF CARE PROJECT IN TORONTO, CANADA

2:00 PM - 2:15 PM

Abstract

Speaker Presentation

Video Recording

Biography

Jennifer Broad is a Community Support Worker with the Toronto Community Hep C Program where she co-facilitates treatment support groups and co-coordinates a research project evaluating peer-delivered point-of-care antibody outreach HCV testing. Jennifer has published and presented on the involvement of people with lived experience in HCV care both nationally and internationally.
Dr Phillip Read
Director
Kirketon Road Centre

MAXIMISING ADHERENCE TO DIRECT-ACTING ANTIVIRALS AMONG STREET-BASED AND MARGINALISED CLIENTS: THE RESULTS OF DAILY DOSING

2:15 PM - 2:30 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr Phillip Read is the Director of the Kirketon Road Centre, a primary health care facility in Sydney, Australia, involved in the prevention, treatment and care of viral hepatitis among people who inject drugs.
Ms Stelliana Goutzamanis
Phd Student
Burnet Institute

CHANGES IN ATTITUDES, KNOWLEDGE AND EVERYDAY LIFE THROUGHOUT DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A LONGITUDINAL QUALITATIVE STUDY

2:30 PM - 2:45 PM

Abstract

Speaker Presentation

Video Recording

Biography

Stelliana is a PhD student at the Burnet Institute and Monash University. Her work focuses on the impact of DAA hepatitis C treatment on health, wellbeing and everyday life.
Dr. Rod Knight
Assistant Professor
British Columbia Centre on Substance Use

FACTORS THAT INFLUENCE PEOPLE WHO USE DRUGS’ EXPERIENCES WITH DIRECT-ACTING ANTIVIRAL TREATMENT FOR HEPATITIS C: A QUALITATIVE STUDY IN VANCOUVER, CANADA

2:45 PM - 2:50 PM

Abstract

Speaker Presentation

Video Recording

Biography

Rod Knight is an Assistant Professor at UBC's Department of Medicine and a Research Scientist at the BC Centre on Substance Use.
Dr John Koo
Resident
Ubc Internal Medicine/Vancouver Coastal Health

DISPENSING MODE AND HEPATITIS C DIRECT ACTING ANTIVIRAL TREATMENT COMPLETION

2:50 PM - 2:55 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr. Koo is an internal medicine resident physician at University of British Columbia (UBC). He completed a masters program in clinical epidemiology and research methodology at UBC and is currently engaging in various infectious diseases research.
Ms. Tianna Magel
Research Associate
Vancouver Infectious Diseases Centre

HCV SUPPORT GROUPS: DO THEY STILL HAVE A ROLE IN THE DAA ERA?

2:55 PM - 3:00 PM

Abstract

Speaker Presentation

Video Recording

Biography

Tianna received her B.A from the University of British Columbia. She currently works as a research assistant at Vancouver Infectious Diseases Centre where she researches HCV/HIV in vulnerable populations.
Agenda Item Image
Ms Sadeem Fayed
Graduate Student
Simon Fraser University

PEERS4WELLNESS: INDIGENOUS MODEL FOR SUPPORTIVE HCV AND HIV CARE

3:00 PM - 3:05 PM

Abstract

Speaker Presentation

Video Recording

Biography

Sadeem is a researcher with indigenouswellness.Ca. She works under the mentorship of Dr. Alexandra King and Dr. Malcolm King. She is pursuing a Masters in Public Health (MPH) at Simon Fraser University. Her research interests include Indigenous wellness and health, with focus on hepatitis C and HIV in Canadian contexts.
Mr Matthew Fischer
Community Researcher
Indigenous Wellness Research Group

A TWO-EYED SEEING APPROACH TO WHOLISTIC HEALING AND WELLNESS FOR PEOPLE WITH DRUG USE EXPERIENCE

3:05 PM - 3:10 PM

Abstract

Speaker Presentation

Video Recording

Biography

A proud Mi'kmaq from Newfoundland. I have lived in most provinces of Canada and have always been drawn to First Nations and Inuit cultures. In the last five years, I have been working and volunteering with an AIDS organization and now expanded into Indigenous health research initiatives.
Ms Nikitah Habraken
Program Manager
Australasian Society For HIV, Viral Hepatitis And Sexual Health Medicine (ASHM)

ENHANCED SELF-EFFICACY FOR HCV MANAGEMENT AMONG PEOPLE PARTICIPATING AN HCV EDUCATION PROGRAM FOCUSED ON DRUG AND ALCOHOL AND PRIMARY CARE SETTINGS

3:10 PM - 3:15 PM

Abstract

Speaker Presentation

Video Recording

Biography

Nikitah Habraken is the Acting Hepatitis C Program Manager at the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). In collaboration with INHSU and the Kirby Institute at the University of New South Wales (UNSW) she leads an international education program designed to upskill health professionals, with the aim of expanding hepatitis C care beyond hospital settings
Dr Benjamin Eckhardt
Assistant Professor
NYU School of Medicine

ACCESSIBLE CARE INTERVENTION FOR ENGAGING PEOPLE WHO INJECT ILLICIT DRUGS IN HEPATITIS C VIRUS CARE: PRELIMINARY RESULTS FROM A RANDOMIZED CLINICAL TRIAL

3:15 PM - 3:20 PM

Abstract

Speaker Presentation

Video Recording

Biography

Dr. Eckhardt is an Assistant Professor at the NYU School of Medicine and Attending Physician at Bellevue Hospital in New York City. His research interest focuses on evaluating models of care to facilitate access, engagement, and retention of active injection drug users in HCV treatment and care.

Chair

Mel Krajden
Medical Director, Bccdc Public Health Laboratory
BC Centre For Disease Control

Lise Lafferty
Research Fellow
UNSW Sydney

loading